In Vitro Development of Mouse and Human NK Cells from Hematopoietic Progenitor Cells
Ines Ullmo1, Nahide Koksal1, Heather Y K Ang1
1Department of Life Sciences, Imperial College London, London, UK.
Methods in Molecular Biology (Clifton, N.J.)
|March 28, 2022
Summary
Natural killer (NK) cell research is advancing cancer immunotherapy. New in vitro methods enhance the production of functional NK cells from hematopoietic progenitor cells for research and clinical applications.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Natural killer (NK) cells are crucial lymphocytes for eliminating virally infected and cancerous cells.
- NK cell adoptive transfer shows promise in cancer immunotherapy, driving interest in their clinical application.
- A key challenge is enhancing the ex vivo production of large numbers of functional NK cells for therapeutic use.
Purpose of the Study:
- To describe robust in vitro assays for studying NK cell development.
- To provide protocols for generating human and mouse NK cells from hematopoietic progenitor cells (HPCs).
- To facilitate investigation into NK cell development and function for immunotherapy research.
Main Methods:
- Development of two distinct in vitro NK cell development assays.
- Utilizing hematopoietic progenitor cells (HPCs) as the starting material.
- Specific protocols established for both human and mouse NK cell generation.
Main Results:
- Successful establishment of two reliable in vitro NK cell development assays.
- Demonstrated feasibility of generating NK cells from HPCs in vitro.
- Protocols are suitable for investigating NK cell development and function.
Conclusions:
- The described in vitro assays provide robust methods for NK cell research.
- These protocols can aid in overcoming challenges in ex vivo NK cell expansion for immunotherapy.
- The methods support further investigation into NK cell biology and therapeutic potential.
